Direct-to-Consumer Pharmacies: Practice Implications for Gastroenterology and Hepatology
Clinical Gastroenterology and Hepatology · 2026-08 · 24 (8) · 2049-2054
DOI: 10.1016/j.cgh.2026.04.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-08. Verfasst von Siddharth Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona. Electronic address: singh.siddharth@ma…. Die Arbeit nennt 6 Literaturangaben. Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona. Electronic address: singh.siddharth@mayo.edu.
- Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts.
- Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona.
Förderung
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Singh, S., Dapke, K., & Ivanov, M. (2026). Direct-to-Consumer Pharmacies: Practice Implications for Gastroenterology and Hepatology. Clinical Gastroenterology and Hepatology, 24(8), 2049-2054. https://doi.org/10.1016/j.cgh.2026.04.021
Vancouver
Singh S, Dapke K, Ivanov M. Direct-to-Consumer Pharmacies: Practice Implications for Gastroenterology and Hepatology. Clinical Gastroenterology and Hepatology. 2026;24(8):2049-2054. doi:10.1016/j.cgh.2026.04.021
BibTeX
@article{Singh2026,
author = {Singh, Siddharth and Dapke, Kartik and Ivanov, Marina},
title = {Direct-to-Consumer Pharmacies: Practice Implications for Gastroenterology and Hepatology},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
volume = {24},
number = {8},
pages = {2049--2054},
doi = {10.1016/j.cgh.2026.04.021}
}
EUVIMED